HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
When do Heparin Sodium 10,000 Units In Dextrose 5% patents expire, and when can generic versions of Heparin Sodium 10,000 Units In Dextrose 5% launch?
Heparin Sodium 10,000 Units In Dextrose 5% is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% is heparin sodium. Twenty-five suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Sodium 10,000 Units In Dextrose 5%
A generic version of HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%?
- What are the global sales for HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%?
- What is Average Wholesale Price for HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%?
Summary for HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
US Patents and Regulatory Information for HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% | heparin sodium | INJECTABLE;INJECTION | 018911-006 | Jan 30, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 019339-003 | Mar 27, 1985 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
